Market Cap 48.67M
Revenue (ttm) 83.81M
Net Income (ttm) -240.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -287.22%
Debt to Equity Ratio -2.02
Volume 1,245,100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 9.79M
Stochastic %K N/A
Beta 0.27
Analysts Hold
Price Target $9.33

Company Profile

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cereb...

Industry: Biotechnology
Sector: Healthcare
Phone: 339 499 9300
Address:
455 Grand Union Boulevard, Somerville, United States
QLBatiatus
QLBatiatus Jul. 15 at 3:56 PM
$BLUE The hate I have for the managers of this disaster is epic. What a shame for patients …this was my last foray into bio Pharma - f Pharma stocks and bios - corruption, incompetence, lawsuits….never again!!!!
0 · Reply
MF__DOOM
MF__DOOM Jul. 14 at 5:20 PM
$CRSP easy short, the same people who blocked me when this hit $32-30 range from $50S are the same ones who will miss out on money again and not ride this back down to $45-40 range Also collected a nice call premium riding Crspr from $32 to lower $50 I said it for a year crispr would touch lower $30S and so many posted against me that most now blocked me when we hit $31 range 😂 I’m not a premabear like some think because I came from $BLUE but I said it almost 2 years ago now once blue began collapsing in the buyout process that $CRSP was gonna follow and it did Also many who post against me said neither blue nor crispr was gonna get bought out…blue got Bo and said it 3-4years+ ago now at this point and it was so obvious back then (the fact that it got an incredibly shitty BO was a little harder to predict, sadly) Now with blue in private sector by Carlyle many of you will get caught off by price action based on the board posts here, don’t be fooled by perma bulls…this does have potential if this stock goes the right way but on a technical level it’s over extended now so if you’re long term keep holding and wait a little to avg. down/up because price in the short term is gonna get much cheaper and once those targets ($45-40) are reached and if news comes out accordingly then this could see $80-100 but currently that ain’t gonna be a straight line upward. $CG $XBI
3 · Reply
gargoyl
gargoyl Jul. 9 at 3:12 PM
$BLRX 👀 runner ?? 🏃‍♀️ 🩳 * * * 🔫 Percolating $BMY $VSTM @ peeps at $BLUE
0 · Reply
Rnerdz
Rnerdz Jul. 9 at 12:18 PM
$BLUE who’s buyin??
1 · Reply
gargoyl
gargoyl Jul. 7 at 5:17 PM
$BLUE back to $5 , life is good
0 · Reply
Harvard_MBA
Harvard_MBA Jul. 3 at 4:59 PM
$IOVA, you are likely right. This company simply has no plan on how to make money. The treatment is simply too complex and too expensive and the patient pool too small. If there is a market downdraft this could be below a $1 in a blink. I believe the best strategy is to shelve their pipeline and try and find a private equity firm to take them over. Much like $BLUE. A $70M market cap sounds reasonable.
3 · Reply
Obiwan123
Obiwan123 Jul. 3 at 2:21 PM
$BLUE the company that ruined their shareholders.
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting -2.52 EPS for $BLUE Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/blue?chart=historical&metric_name=eps&utm_c
0 · Reply
GoldenTradesCapital
GoldenTradesCapital Jun. 30 at 8:29 AM
MARKET UPDATE: TOP NASDAQ LOSERS THIS WEEK 📉 • $LCID -12.3% • $CVNA -10.8% • $BBBYQ -10.1% • $NKLA -9.5% • $BLUE -8.9% Follow us to stay on top of the market 🔱
0 · Reply
Letsinvest2024
Letsinvest2024 Jun. 28 at 9:58 PM
$BLUE I wanted to choose the $5 cash option but I missed the due date.🙄 At least I still have some rights in the future. Per ChatGPT: While it's possible for a company to manipulate operations to avoid a CVR payout, doing so can lead to serious legal, financial, and reputational consequences. CVR holders often have contractual and legal protections to challenge such actions. If you’re involved with a CVR — as a holder or within a company — it’s wise to consult with legal counsel to understand your rights and obligations.
0 · Reply
Latest News on BLUE
Bluebird bio receives non-binding bid for up to $110.5 million

Mar 28, 2025, 5:43 PM EDT - 3 months ago

Bluebird bio receives non-binding bid for up to $110.5 million


bluebird bio Announces 1-for-20 Reverse Stock Split

Dec 4, 2024, 4:05 PM EST - 7 months ago

bluebird bio Announces 1-for-20 Reverse Stock Split


bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 10:06 AM EST - 8 months ago

bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript


Bluebird Bio (BLUE) Stock Dips Amid Market Volatility

Oct 8, 2024, 3:53 PM EDT - 10 months ago

Bluebird Bio (BLUE) Stock Dips Amid Market Volatility


Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements

Oct 2, 2024, 4:11 PM EDT - 10 months ago

Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements


bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing

Sep 27, 2024, 4:30 PM EDT - 10 months ago

bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing


Bluebird bio to cut 25% of workforce as part of restructuring

Sep 24, 2024, 7:08 AM EDT - 10 months ago

Bluebird bio to cut 25% of workforce as part of restructuring


bluebird bio Announces September Investor Events

Aug 28, 2024, 8:00 AM EDT - 11 months ago

bluebird bio Announces September Investor Events


bluebird bio Announces Receipt of Expected Notices from Nasdaq

Aug 23, 2024, 4:05 PM EDT - 11 months ago

bluebird bio Announces Receipt of Expected Notices from Nasdaq


bluebird bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 11:14 AM EDT - 11 months ago

bluebird bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript


QLBatiatus
QLBatiatus Jul. 15 at 3:56 PM
$BLUE The hate I have for the managers of this disaster is epic. What a shame for patients …this was my last foray into bio Pharma - f Pharma stocks and bios - corruption, incompetence, lawsuits….never again!!!!
0 · Reply
MF__DOOM
MF__DOOM Jul. 14 at 5:20 PM
$CRSP easy short, the same people who blocked me when this hit $32-30 range from $50S are the same ones who will miss out on money again and not ride this back down to $45-40 range Also collected a nice call premium riding Crspr from $32 to lower $50 I said it for a year crispr would touch lower $30S and so many posted against me that most now blocked me when we hit $31 range 😂 I’m not a premabear like some think because I came from $BLUE but I said it almost 2 years ago now once blue began collapsing in the buyout process that $CRSP was gonna follow and it did Also many who post against me said neither blue nor crispr was gonna get bought out…blue got Bo and said it 3-4years+ ago now at this point and it was so obvious back then (the fact that it got an incredibly shitty BO was a little harder to predict, sadly) Now with blue in private sector by Carlyle many of you will get caught off by price action based on the board posts here, don’t be fooled by perma bulls…this does have potential if this stock goes the right way but on a technical level it’s over extended now so if you’re long term keep holding and wait a little to avg. down/up because price in the short term is gonna get much cheaper and once those targets ($45-40) are reached and if news comes out accordingly then this could see $80-100 but currently that ain’t gonna be a straight line upward. $CG $XBI
3 · Reply
gargoyl
gargoyl Jul. 9 at 3:12 PM
$BLRX 👀 runner ?? 🏃‍♀️ 🩳 * * * 🔫 Percolating $BMY $VSTM @ peeps at $BLUE
0 · Reply
Rnerdz
Rnerdz Jul. 9 at 12:18 PM
$BLUE who’s buyin??
1 · Reply
gargoyl
gargoyl Jul. 7 at 5:17 PM
$BLUE back to $5 , life is good
0 · Reply
Harvard_MBA
Harvard_MBA Jul. 3 at 4:59 PM
$IOVA, you are likely right. This company simply has no plan on how to make money. The treatment is simply too complex and too expensive and the patient pool too small. If there is a market downdraft this could be below a $1 in a blink. I believe the best strategy is to shelve their pipeline and try and find a private equity firm to take them over. Much like $BLUE. A $70M market cap sounds reasonable.
3 · Reply
Obiwan123
Obiwan123 Jul. 3 at 2:21 PM
$BLUE the company that ruined their shareholders.
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting -2.52 EPS for $BLUE Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/blue?chart=historical&metric_name=eps&utm_c
0 · Reply
GoldenTradesCapital
GoldenTradesCapital Jun. 30 at 8:29 AM
MARKET UPDATE: TOP NASDAQ LOSERS THIS WEEK 📉 • $LCID -12.3% • $CVNA -10.8% • $BBBYQ -10.1% • $NKLA -9.5% • $BLUE -8.9% Follow us to stay on top of the market 🔱
0 · Reply
Letsinvest2024
Letsinvest2024 Jun. 28 at 9:58 PM
$BLUE I wanted to choose the $5 cash option but I missed the due date.🙄 At least I still have some rights in the future. Per ChatGPT: While it's possible for a company to manipulate operations to avoid a CVR payout, doing so can lead to serious legal, financial, and reputational consequences. CVR holders often have contractual and legal protections to challenge such actions. If you’re involved with a CVR — as a holder or within a company — it’s wise to consult with legal counsel to understand your rights and obligations.
0 · Reply
jewell69
jewell69 Jun. 28 at 2:34 AM
YOU ARE RITE ! I WAS PAID 3.00 PLUS 096CVR030 CUSIP; NOT SURE VALUE OR TIMIN OF NEXT PAYMENT. $BLUE
1 · Reply
ikkydiphoenix
ikkydiphoenix Jun. 27 at 7:45 PM
$TSBX bought some at 0.35 .. maybe somebody will make a better offer, like it happened with $BLUE
0 · Reply
GoldenTradesCapital
GoldenTradesCapital Jun. 27 at 5:26 PM
MARKET UPDATE: TOP NASDAQ LOSERS THIS WEEK 📉 • $LCID -12.3% • $CVNA -10.8% • $BBBYQ -10.1% • $NKLA -9.5% • $BLUE -8.9% Follow us to stay on top of the market 🔱
0 · Reply
jewell69
jewell69 Jun. 27 at 3:50 PM
$BLUE ALSO NOW OWN: 0 VALUE, BUT WE OWN IT ! Date Jun-26-2025 Symbol 096CVR030 Symbol description BLUEBIRD BIO IN CONTRA Type Cash Shares +200.000
0 · Reply
jewell69
jewell69 Jun. 27 at 3:48 PM
$BLUE paid today 3.00 per 6/27/25 Symbol description BLUEBIRD BIO INC ESC *EXCHANGED FOR CUSIP 096CVR030 + $ 3.00* Type Cash Shares -200.000 Price $3.00 Amount $600.00
1 · Reply
TAG01
TAG01 Jun. 27 at 2:40 PM
$BLUE good bye blue forever been a learning experience how bad managment and company philosophy and on small FDA voucher not achieved can run something good for people into the ground. best of luck on recovery for those who lost. i sure hope they clean out managment.
1 · Reply
Digmore
Digmore Jun. 26 at 10:11 PM
$BLUE Wheres my fukn money you crooks !!!!
1 · Reply
DeFiKing
DeFiKing Jun. 25 at 6:35 PM
$CRSP remember a year ago ppl were comparing this to $BLUE lol. Where are they now
2 · Reply
ElonBust
ElonBust Jun. 25 at 5:55 PM
$SRPT is loooking like $BLUE 2.0 though
1 · Reply
Harvard_MBA
Harvard_MBA Jun. 25 at 4:38 PM
$IOVA This stock is going the way of $BLUE. Like BLUE this stock has no way to make any money. Your investment is completely destroyed. Don't blame anyone else but yourself. You tried to get rich quick on a biotech and it blew up all over your face. Now you get taxed.
2 · Reply
Kevinhall2
Kevinhall2 Jun. 24 at 11:04 PM
$BLUE can someone explain to me why on the Webull trading platform I was awarded the $3 per share on June 2nd or 3rd only for them to change the ticker and take back the $3 per share saying since ticker change a 1:1 conversion was done with no cash payout. Essentially I took the $3 per share and invested in other companies. Then a week later change ticker and take back the $3 per share which threw my account in a RM call and due to that had to sell around $1100 dollars worth of stocks to take RM call away which created over a $1000 in P&L losses. Have been back and forth with company that handled merger and Webull. Merger company doesnt understand why they recalled the $3 a share and Webull will not explain except the ticker change. Looking for advice from anyone that may know the answer or if anyone else has had same thing happen to them.
1 · Reply
AtotheZ
AtotheZ Jun. 23 at 9:16 PM
$BLUE fidelity never sent me shit for this which is annoying
1 · Reply